The main purpose of the Eliminating Thickets to Increase Competition Act, also known as the ETHIC Act, is to simplify the patent process in the pharmaceutical industry. It aims to reduce the complexity and number of patents that can be asserted in legal actions related to drug approvals and biological products. This is intended to foster competition and make it easier for new drugs and treatments to enter the market.